Pinos Elisabet de los

CIK: 0001889633

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (53.8%)

Position reduction

Option Exercises (M)3 (23.1%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (7.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AURA

Aura Biosciences, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

AURA
Aura Biosciences, Inc.
Mar 2, 2026
Award(A)
Direct
166K shares-
AURA
Aura Biosciences, Inc.
Feb 17, 2026
Sale(S)
Direct
47.6K shares at avg. $5.06$241K
AURA
Aura Biosciences, Inc.
Jan 20, 2026
Sale(S)
Direct
16.9K shares at avg. $4.86$82K
AURA
Aura Biosciences, Inc.
Oct 29, 2025
Sale(S)
Direct
9K shares at avg. $6.35$57K
AURA
Aura Biosciences, Inc.
Jun 2, 2025
Exercise(M)
Direct
10.9K shares at avg. $5.07$56K
AURA
Aura Biosciences, Inc.
Jun 2, 2025
Tax Payment(F)
Direct
9.9K shares at avg. $6.16$61K
AURA
Aura Biosciences, Inc.
Feb 18, 2025
Sale(S)
Direct
20.2K shares at avg. $7.75$157K
AURA
Aura Biosciences, Inc.
Feb 3, 2025
Award(A)
Direct
194.3K shares-
AURA
Aura Biosciences, Inc.
Jan 21, 2025
Sale(S)
Direct
16K shares at avg. $7.67$122K
AURA
Aura Biosciences, Inc.
Oct 29, 2024
Sale(S)
Direct
9.2K shares at avg. $10.74$99K
AURA
Aura Biosciences, Inc.
Oct 18, 2024
Exercise(M)
Direct
25K shares at avg. $2.74$68K
AURA
Aura Biosciences, Inc.
Oct 18, 2024
Sale(S)
Direct
25K shares at avg. $12.04$301K
AURA
Aura Biosciences, Inc.
Sep 27, 2024
Exercise(M)
Direct
5.5K shares at avg. $5.76$32K

		Type	Shares	Price		Ownership
Mar 2, 2026	AURA Aura Biosciences, Inc.	Award(A)	166,000	-	$0	Direct
Feb 17, 2026	AURA Aura Biosciences, Inc.	Sale(S)	47,648	$5.06	$241,099	Direct
Jan 20, 2026	AURA Aura Biosciences, Inc.	Sale(S)	16,928	$4.86	$82,270	Direct
Oct 29, 2025	AURA Aura Biosciences, Inc.	Sale(S)	9,049	$6.35	$57,461	Direct
Jun 2, 2025	AURA Aura Biosciences, Inc.	Exercise(M)	10,948	$5.07	$55,506	Direct
Jun 2, 2025	AURA Aura Biosciences, Inc.	Tax Payment(F)	9,948	$6.16	$61,280	Direct
Feb 18, 2025	AURA Aura Biosciences, Inc.	Sale(S)	20,221	$7.75	$156,796	Direct
Feb 3, 2025	AURA Aura Biosciences, Inc.	Award(A)	194,320	-	-	Direct
Jan 21, 2025	AURA Aura Biosciences, Inc.	Sale(S)	15,955	$7.67	$122,381	Direct
Oct 29, 2024	AURA Aura Biosciences, Inc.	Sale(S)	9,200	$10.74	$98,788	Direct
Oct 18, 2024	AURA Aura Biosciences, Inc.	Exercise(M)	24,992	$2.74	$68,478	Direct
Oct 18, 2024	AURA Aura Biosciences, Inc.	Sale(S)	24,992	$12.04	$300,839	Direct
Sep 27, 2024	AURA Aura Biosciences, Inc.	Exercise(M)	5,474	$5.76	$31,530	Direct

1-13 of 13 transactions

About de los Pinos Elisabet

de los Pinos Elisabet (SEC CIK 0001889633) files insider reports with the SEC as Director of Aura Biosciences, Inc. (AURA).

Signal8 holds 11 ownership filings by de los Pinos Elisabet, all Form 4s, filed between Oct 1, 2024 and Mar 3, 2026. Those filings report 13 transactions, from Sep 27, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on de los Pinos Elisabet's filings is in BOSTON, MA.

Recent filings by de los Pinos Elisabet

Mar 2, 2026: Grant or award of AURA shares (Form 4, code A).
Feb 17, 2026: Open-market sale of AURA shares (Form 4, code S).
Jan 20, 2026: Open-market sale of AURA shares (Form 4, code S).
Oct 29, 2025: Open-market sale of AURA shares (Form 4, code S).
Jun 2, 2025: Option exercise of AURA shares (Form 4, code M).

Other insiders filing for Aura Biosciences, Inc. (AURA)

Person Julie, Chief People Officer
Kratz Erica, Chief Reg. & Quality Officer
Hopkins Janet Jill, Chief Medical Officer
Elazzouzi Amy, SVP, Finance & PAO
Abu-Absi Susan, Chief Operating Officer
Bender Jeremy, Director

How to read Form 4 transaction codes